Difference between revisions of "Moclobemide-bupropion"

From Psychiatrienet
Jump to: navigation, search
 
(One intermediate revision by the same user not shown)
Line 3: Line 3:
 
| to = bupropion  
 
| to = bupropion  
 
| stop =  
 
| stop =  
{{stopMoclobemide}}
+
{{generaldecrease25p3d}}
 +
{{24Hwashout}}
 
| start =   
 
| start =   
* '''Day 9:'''  start bupropion after this period in a normal dosage of 150 mg/day.
+
{{generalstart}}
  
 
| info =  
 
| info =  
{{Shortt1/2}}
+
{{mocloshorthalflife}}
 
}}
 
}}

Latest revision as of 15:32, 17 June 2016

Moclobemide
Type Antidepressant
Group MAO-I
links
Medscape Moclobemide
PubChem 4235
PubMed Moclobemide
Kompas (Dutch) Moclobemide
Wikipedia Moclobemide
Bupropion
Type Antidepressant
Group other
links
ATC-code N06AX12
Medscape Bupropion
PubChem 444
PubMed Bupropion
Kompas (Dutch) Bupropion
Wikipedia Bupropion

Switch medication from moclobemide to bupropion.

Nietinrijdenbord.png Stop moclobemide
  • Decrease with about 25% of original dose every 3 days
  • Stop and wait for about 24 hour as a washout period
Eenrichtingbord.png Start bupropion
  • Start with the initial dose
Infobord.png More information
  • Because of the short half life of moclobemide (approx. 2h), the next antidepressant can start next day after stopping with moclobemide.[1]
  1. Keks, Nicholas, J. Hope, and S. Keogh. "Switching and stopping antidepressants." Australian Prescriber 39.3 (2016).
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.